...
首页> 外文期刊>Digestive surgery >Transanal Endoscopic Microsurgery with or without Completion Total Mesorectal Excision for T2 and T3 Rectal Carcinoma
【24h】

Transanal Endoscopic Microsurgery with or without Completion Total Mesorectal Excision for T2 and T3 Rectal Carcinoma

机译:具有或不完全完成T2和T3直肠癌的TransAnosphopopopic Microsergery

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: Transanal endoscopic microsurgery (TEM) is used for the resection of large rectal adenomas and well or moderately differentiated T1 carcinomas. Due to difficulty in preoperative staging, final pathology may reveal a carcinoma not suitable for TEM. Although completion total mesorectal excision is considered standard of care in T2 or more invasive carcinomas, this completion surgery is not always performed. The purpose of this article is to evaluate the outcome of patients after TEM-only, when completion surgery would be indicated. Methods: In this retrospective multicenter, observational cohort study, outcome after TEM-only (n = 41) and completion surgery (n = 40) following TEM for a pT2-3 rectal adenocarcinoma was compared. Results: Median follow-up was 29 months for the TEM-only group and 31 months for the completion surgery group. Local recurrence rate was 35 and 11% for the TEM-only and completion surgery groups respectively. Distant metastasis occurred in 16% of the patients in both groups. The 3-year overall survival was 63% in the TEM-only group and 91% in the completion surgery group respectively. Three-year disease-specific survival was 91 versus 93% respectively. Conclusions: Although local recurrence after TEM-only for pT2-3 rectal cancer is worse compared to the recurrence that occurs after completion surgery, disease-specific survival is comparable between both groups. The lower unadjusted overall survival in the TEM-only group indicates that TEM-only may be a valid alternative in older and frail patients, especially when high morbidity of completion surgery is taken into consideration. Nevertheless, completion surgery should always be advised when curation is intended. (C) 2018 The Author(s) Published by S. Karger AG, Basel
机译:目的:常规内窥镜显微外科(TEM)用于切除大肠腺瘤和井或中度分化的T1癌。由于术前分期困难,最终病理可能会揭示不适合TEM的癌症。虽然完成总培素切除在T2或更多侵入性癌症中被认为是护理标准,但并不总是进行这种完成手术。本文的目的是在表明完成手术后,评估患者的结果。方法:在这种回顾性多中心,观察队列研究中,比较了TEM-PTO-PT2-3直肠腺癌的TEM仅(n = 41)和完成手术(n = 40)后的结果。结果:Tem-of Tem-Press Group的中位后续时间为29个月,完成手术组31个月。局部复发率分别为35%至11%,分别为TEM和完成手术组。两组患者的16%发生了远端转移。 TEM-PROSION的3年整体存活率分别为63%,分别在完工外科小组中获得91%。三年的疾病特异性存活率分别为91%。结论:虽然PT2-3的TEM-PT2-3后的局部复发与完成手术后发生的复发相比,但两组之间的疾病特异性存活率比较差。 Tem-ock中的未经调整的整体生存率较低表明,TEM-ock患者中仅为有效的替代品,特别是当考虑完成手术的高发病率时。尽管如此,应始终建议策委的完成手术。 (c)2018年由巴塞尔的S. Karger AG发布的提交人

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号